Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Y Chang

Showing results (231-240 of 282) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2018
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor ModelSharareh Niknam, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
Head & Neck|March 5, 2020
Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancerDario Pasalic, Sonia L Betancourt-Cuellar, Nicolette Taku, et al.
JAMA Network Open|January 16, 2019
Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerEric D Brooks, Bing Sun, Lei Feng, et al.
JAMA Oncology|July 21, 2017
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 StudyJoe Y Chang, Vivek Verma, Ming Li, et al.
The Annals of Thoracic Surgery|August 25, 2010
Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan statusMin P Kim, Arlene M Correa, Jared Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|April 4, 2025
American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive SummaryCharles B Simone, Arya Amini, Indrin J Chetty, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2020
Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLCOlsi Gjyshi, Ting Xu, Adnan Elhammali, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2016
Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II TrialJames W Welsh, Steven N Seyedin, Pamela K Allen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 23, 2024
American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic RadiotherapyArya Amini, Vlad G Zaha, Eman Hamad, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life CareMatthew S Ning, Prajnan Das, David I Rosenthal, et al.
Pageof 29

Showing results (231-240 of 282) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2018
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor ModelSharareh Niknam, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
Head & Neck|March 5, 2020
Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancerDario Pasalic, Sonia L Betancourt-Cuellar, Nicolette Taku, et al.
JAMA Network Open|January 16, 2019
Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerEric D Brooks, Bing Sun, Lei Feng, et al.
JAMA Oncology|July 21, 2017
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 StudyJoe Y Chang, Vivek Verma, Ming Li, et al.
The Annals of Thoracic Surgery|August 25, 2010
Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan statusMin P Kim, Arlene M Correa, Jared Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|April 4, 2025
American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive SummaryCharles B Simone, Arya Amini, Indrin J Chetty, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2020
Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLCOlsi Gjyshi, Ting Xu, Adnan Elhammali, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2016
Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II TrialJames W Welsh, Steven N Seyedin, Pamela K Allen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 23, 2024
American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic RadiotherapyArya Amini, Vlad G Zaha, Eman Hamad, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life CareMatthew S Ning, Prajnan Das, David I Rosenthal, et al.
Pageof 29